Skip to content

Swallowing improvement and hemodynamic signal changes of transcranial direct current stimulation combined electromyographic biofeedback on stroke patients with dysphagia: A randomized controlled study

Swallowing improvement and hemodynamic signal changes of transcranial direct current stimulation combined electromyographic biofeedback on stroke patients with dysphagia: A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109618
Enrollment
Unknown
Registered
2025-09-23
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:Transcranial direct current stimulation combined with electromyographic biofeedback
Control group:Pseudo-transcranial direct current stimulation combined with electromyographic biofeedback

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of stroke in the Chinese Guidelines for the diagnosis and treatment of acute ischemic stroke (2018 edition) or the Chinese Guidelines for the diagnosis and treatment of cerebral hemorrhage (2019 edition), and the diagnosis was confirmed by head CT or MRI; (2) First-episode unilateral cerebral hemisphere stroke patients in the subacute phase (1 week-6 months after onset); 3. The age of onset was 18-80 years old, and the condition was stable; 4. Dysphagia was diagnosed by fiberoptic endoscopic evaluation of swallowing (FEES); 5. Normal cognitive function and able to cooperate with the examination; 6. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Dysphagia caused by other neurogenic diseases such as Parkinson's disease, brain trauma, head and neck cancer after radiotherapy, or organic swallowing dysfunction; 2. Previous cerebrovascular disease; 3. Suffering from serious kidney, liver, cardiovascular or severe hematopoietic diseases; 4. Patients with epilepsy or family members with epilepsy; 5. Patients with contraindications to tDCS therapy, such as cochlear implants, implantable devices (e.g. Deep brain stimulation, ventriculoperitoneal shunt), or cerebral aneurysm clips, who are allergic to the electrode patch.

Design outcomes

Primary

MeasureTime frame
Functional Oral Feeding Scale score;

Secondary

MeasureTime frame
Score of the Standard Swallowing Function Evaluation Scale;Surface electromyography;Functional near-infrared spectroscopy;

Countries

China

Contacts

Public ContactBangzhong Liu

Zhongshan Hospital, Fudan University

liu.bangzhong@zs-hospital.sh.cn+86 135 6415 6927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026